Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases 2.0
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 7409
Special Issue Editors
Interests: immunology; immune homeostasis; immunotherapy; host-pathogen interaction
Special Issues, Collections and Topics in MDPI journals
Interests: DNA vaccine; immune responses; infectious disease; plasmids; vaccine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The importance of vaccination has gained much attention, again, due to the advent of COVID-19 pandemic. The pioneering vaccinology research of many scientists to eradicate and control various infectious diseases, including polio, Rinderpest and smallpox, diphtheria, rubella, measles, mumps, respectively, has come true via vaccines. However, despite decades of research, many diseases, including bacterial, fungal, parasitic and viral, are not having efficacious vaccines. The ultimate goal of vaccination is to generate a safe and effective long-term immune response against targeted disease.
Vaccine adjuvants and/or immunomodulators, either directly or indirectly, have become an indispensable component for many (if not all) vaccines, including RNA, DNA, recombinant proteins, inactivated and attenuated, and viral vector vaccines. Though limited number of adjuvants have entered clinical phase, various adjuvants/immunomodulators have been explored in the experimental vaccines against various diseases. Although many adjuvants' precise mechanisms of action are not known, they enhance the immune response of antigen through modulation of innate and adaptive immune responses, thus providing long-lasting immunological memory.
We invite potential researchers to submit a research article or a comprehensive/mini/ opinion review article related to vaccines and vaccine adjuvants/immunomodulators against infectious diseases. The specific themes are, including but not limited to:
- Development of novel vaccines against infectious diseases
- Strategies to overcome the current challenges in the development of various vaccines against infectious diseases
- Preparation of antigens for recombinant vaccines.
- Role of adjuvants/immunomodulators in vaccines against infectious diseases
- The potential use of novel delivery systems, including emulsions, liposomes, and other nano/microparticle-based systems, for vaccines
- Effect of route of administration on vaccine efficacy
- Characterisation and immunological evaluation of vaccine delivery systems
- Immunopharmacological evaluation of vaccines and/or vaccine adjuvants/immunomodulators
- Proof-of-concept studies of mechanisms of action of adjuvants/immunomodulator
Preference will be given to articles, which focus on emerging infectious agents (e.g., Coronavirus, Influenza, Hepatitis, Dengue, Malaria and others) in humans or animals.
Prof. Dr. Jagadeesh Bayry
Dr. Srinivasa Reddy Bonam
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
